US2015315231A1PendingUtilityA1
New Steroids Having Increased Water Solubility and Resistance Against Metabolism and Methods For Their Production
Est. expiryNov 21, 2026(~0.4 yrs left)· nominal 20-yr term from priority
A61P 43/00A61P 5/00A61P 5/24A61P 37/08A61P 3/02A61P 25/08A61P 25/26A61P 25/20A61P 25/24A61P 25/02A61P 25/28A61P 3/04A61P 25/00A61P 27/16A61P 27/02A61P 25/22A61P 25/10A61P 27/00A61P 25/14A61P 19/08A61P 15/00A61P 21/00A61P 19/00C07J 7/007C07J 7/002C07J 1/0011C07J 7/0065C07J 41/0016C07J 5/0015C07J 7/00C07J 7/009C07J 41/00C07J 1/00C07J 41/005
53
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Steroid compounds having increased resistance against metabolism and increased water solubility are disclosed, together with methods for their production. These substances are suitable for the manufacture of pharmaceuticals for the treatment of steroid related or steroid induced CNS disorders and for use in methods of prevention, alleviation or treatment of such disorders.
Claims
exact text as granted — not AI-modified1 . The compound 3α-ethynyl, 5α-pregnan-3β,20(R)-diol, or a pharmaceutically acceptable salt thereof.
2 - 14 . (canceled)
15 . A pharmaceutical composition comprising a pharmaceutically effective amount of the compound or a salt thereof according to claim 1 and a pharmaceutically acceptable carrier.
16 - 25 . (canceled)Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.